Jáklová, K.; Feglarová, T.; Rex, S.; Heger, Z.; Eckschlager, T.; Hraběta, J.; Hodek, P.; Kolárik, M.; Indra, R.
Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib. Int. J. Mol. Sci. 2021, 22, 4250.
https://doi.org/10.3390/ijms22084250
AMA Style
Jáklová K, Feglarová T, Rex S, Heger Z, Eckschlager T, Hraběta J, Hodek P, Kolárik M, Indra R.
Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib. International Journal of Molecular Sciences. 2021; 22(8):4250.
https://doi.org/10.3390/ijms22084250
Chicago/Turabian Style
Jáklová, Kateřina, Tereza Feglarová, Simona Rex, Zbyněk Heger, Tomáš Eckschlager, Jan Hraběta, Petr Hodek, Matúš Kolárik, and Radek Indra.
2021. "Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib" International Journal of Molecular Sciences 22, no. 8: 4250.
https://doi.org/10.3390/ijms22084250
APA Style
Jáklová, K., Feglarová, T., Rex, S., Heger, Z., Eckschlager, T., Hraběta, J., Hodek, P., Kolárik, M., & Indra, R.
(2021). Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib. International Journal of Molecular Sciences, 22(8), 4250.
https://doi.org/10.3390/ijms22084250